Manish S Hudlikar

Title: Manish S. Hudlikar: Innovator in Antibody-Drug Conjugates

Introduction

Manish S. Hudlikar is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates (ADCs). His innovative work focuses on enhancing the efficacy of cancer treatments through targeted therapies.

Latest Patents

Manish holds a patent for "Antibody-drug conjugates comprising anti-TM4SF1 antibodies and methods of using the same." This patent describes ADCs that include anti-TM4SF1 antibodies and their antigen-binding fragments. The methods of using these ADCs are also detailed, showcasing their potential in therapeutic applications.

Career Highlights

Manish is currently associated with Angiex, Inc., a company dedicated to advancing cancer therapies. His role at Angiex allows him to leverage his expertise in antibody-drug conjugates to contribute to innovative treatment solutions.

Collaborations

He collaborates with notable colleagues, including Paul A. Jaminet and Shou-Ching S. Jaminet, who share his commitment to advancing medical science through innovative research.

Conclusion

Manish S. Hudlikar's work in the field of antibody-drug conjugates exemplifies the impact of innovation in biotechnology. His contributions are paving the way for more effective cancer treatments, highlighting the importance of targeted therapies in modern medicine.